These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37568347)

  • 21. The Future Role of Cardio-oncologists.
    Pudil R
    Card Fail Rev; 2017 Nov; 3(2):140-142. PubMed ID: 29387468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced Imaging Modalities to Monitor for Cardiotoxicity.
    Seraphim A; Westwood M; Bhuva AN; Crake T; Moon JC; Menezes LJ; Lloyd G; Ghosh AK; Slater S; Oakervee H; Manisty CH
    Curr Treat Options Oncol; 2019 Aug; 20(9):73. PubMed ID: 31396720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do.
    Zito C; Manganaro R; Ciappina G; Spagnolo CC; Racanelli V; Santarpia M; Silvestris N; Carerj S
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
    Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
    Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
    O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential Role of Global Longitudinal Strain in Cardiac and Oncological Patients Undergoing Cardio-Oncology Rehabilitation (CORE).
    Cuomo G; Iannone FP; Di Lorenzo A; Testa C; Ciccarelli M; Venturini E; Cesaro A; Pacileo M; Tagliamonte E; D'Andrea A; Vecchione C; Vigorito C; Giallauria F
    Clin Pract; 2023 Mar; 13(2):384-397. PubMed ID: 36961060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.
    Domercant J; Polin N; Jahangir E
    Ochsner J; 2016; 16(3):250-6. PubMed ID: 27660573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer.
    Karlstaedt A; Moslehi J; de Boer RA
    Nat Rev Cardiol; 2022 Jun; 19(6):414-425. PubMed ID: 35440740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Curing cancer and protecting the heart : Challenges in cardio-oncology in the era of modern tumor treatment].
    Hohmann C; Baldus S; Pfister R
    Herz; 2019 Apr; 44(2):175-188. PubMed ID: 30847511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic.
    Barros-Gomes S; Herrmann J; Mulvagh SL; Lerman A; Lin G; Villarraga HR
    Cardiooncology; 2016 Apr; 2(1):5. PubMed ID: 33530144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardio-oncology for Pediatric and Adolescent/Young Adult Patients.
    Tolani D; Wilcox J; Shyam S; Bansal N
    Curr Treat Options Oncol; 2023 Aug; 24(8):1052-1070. PubMed ID: 37296365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular Oncology: The Need for a Multidisciplinary Approach.
    Ortega Pérez R; Pardo Sanz A; García Gutiérrez V; Zamorano Gómez JL
    Semin Thromb Hemost; 2021 Nov; 47(8):907-913. PubMed ID: 34154001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left Ventricular Dysfunction and Chemotherapeutic Agents.
    Clasen SC; Wald JW
    Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardio-Oncology Rehabilitation-Present and Future Perspectives.
    Elad B; Habib M; Caspi O
    Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardio-oncology: A Focus on Cardiotoxicity.
    Koutsoukis A; Ntalianis A; Repasos E; Kastritis E; Dimopoulos MA; Paraskevaidis I
    Eur Cardiol; 2018 Aug; 13(1):64-69. PubMed ID: 30310475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The breast cancer patient in the cardioncology unit.
    Cardinale D; Caruso V; Cipolla CM
    J Thorac Dis; 2018 Dec; 10(Suppl 35):S4306-S4322. PubMed ID: 30701099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
    Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e45-e54. PubMed ID: 27755242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and Management of Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Children.
    Hegazy M; Ghaleb S; Das BB
    Children (Basel); 2023 Jan; 10(1):. PubMed ID: 36670699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
    Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S45-54. PubMed ID: 27183525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.